These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 35090965)

  • 41. PD-L1 expression and T cells infiltration in patients with uncommon EGFR-mutant non-small cell lung cancer and the response to immunotherapy.
    Chen K; Cheng G; Zhang F; Zhu G; Xu Y; Yu X; Huang Z; Fan Y
    Lung Cancer; 2020 Apr; 142():98-105. PubMed ID: 32120230
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tumor PD-L1 and VEGF Expression, and CD8 T Cell Infiltration Predict Clinical Response to Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer.
    Nojima Y; Shimizu K; Saisho S; Maeda AI; Kurosaki T; Kurose K; Oga T; Oka M; Nakata M
    Anticancer Res; 2021 Nov; 41(11):5469-5475. PubMed ID: 34732416
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combined effects of EGFR tyrosine kinase inhibitors and vATPase inhibitors in NSCLC cells.
    Jin HO; Hong SE; Kim CS; Park JA; Kim JH; Kim JY; Kim B; Chang YH; Hong SI; Hong YJ; Park IC; Lee JK
    Toxicol Appl Pharmacol; 2015 Aug; 287(1):17-25. PubMed ID: 25981168
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HIF-2α not HIF-1α overexpression confers poor prognosis in non-small cell lung cancer.
    Gao ZJ; Wang Y; Yuan WD; Yuan JQ; Yuan K
    Tumour Biol; 2017 Jun; 39(6):1010428317709637. PubMed ID: 28653893
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hypoxia-inducible factor-1α inhibition augments efficacy of programmed cell death 1 antibody in murine prostatic cancer models.
    Shen Z; Pei Q; Zhang H; Yang C; Cui H; Li B; Liu J; Bo Z; Wei F; Zhang M; Liu C
    Anticancer Drugs; 2022 Jul; 33(6):587-594. PubMed ID: 35324523
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Low PD-1 Expression in Cytotoxic CD8
    Mazzaschi G; Madeddu D; Falco A; Bocchialini G; Goldoni M; Sogni F; Armani G; Lagrasta CA; Lorusso B; Mangiaracina C; Vilella R; Frati C; Alfieri R; Ampollini L; Veneziani M; Silini EM; Ardizzoni A; Urbanek K; Aversa F; Quaini F; Tiseo M
    Clin Cancer Res; 2018 Jan; 24(2):407-419. PubMed ID: 29074606
    [No Abstract]   [Full Text] [Related]  

  • 47. Molecular heterogeneity of anti-PD-1/PD-L1 immunotherapy efficacy is correlated with tumor immune microenvironment in East Asian patients with non-small cell lung cancer.
    Jin R; Liu C; Zheng S; Wang X; Feng X; Li H; Sun N; He J
    Cancer Biol Med; 2020 Aug; 17(3):768-781. PubMed ID: 32944405
    [No Abstract]   [Full Text] [Related]  

  • 48. HIF-1-dependent heme synthesis promotes gemcitabine resistance in human non-small cell lung cancers via enhanced ABCB6 expression.
    Xiang L; Wang Y; Lan J; Na F; Wu S; Gong Y; Du H; Shao B; Xie G
    Cell Mol Life Sci; 2022 Jun; 79(6):343. PubMed ID: 35661930
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High co-expression of PD-L1 and HIF-1α correlates with tumour necrosis in pulmonary pleomorphic carcinoma.
    Chang YL; Yang CY; Lin MW; Wu CT; Yang PC
    Eur J Cancer; 2016 Jun; 60():125-35. PubMed ID: 27107327
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Upregulation of hypoxia-inducible factor-1alpha mRNA and its clinical significance in non-small cell lung cancer.
    Yohena T; Yoshino I; Takenaka T; Kameyama T; Ohba T; Kuniyoshi Y; Maehara Y
    J Thorac Oncol; 2009 Mar; 4(3):284-90. PubMed ID: 19190516
    [TBL] [Abstract][Full Text] [Related]  

  • 51. ASCC3 promotes the immunosuppression and progression of non-small cell lung cancer by impairing the type I interferon response via CAND1-mediated ubiquitination inhibition of STAT3.
    Ao YQ; Gao J; Jin C; Wang S; Zhang LC; Deng J; Chen ZW; Wang HK; Jiang JH; Ding JY
    J Immunother Cancer; 2023 Dec; 11(12):. PubMed ID: 38148115
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Programmed death-ligand 1 expression and CD8+ tumor-infiltrating lymphocytes in advanced non-small cell lung cancer treated with microwave ablation and chemotherapy.
    Wei Z; Zhan X; Fan L; Ye X; Yang X; Huang G; Li W; Wang J; Han X; Meng M; Ni Y; Li Q
    Int J Hyperthermia; 2018; 35(1):591-598. PubMed ID: 30307348
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Knockdown of KLF5 suppresses hypoxia-induced resistance to cisplatin in NSCLC cells by regulating HIF-1α-dependent glycolysis through inactivation of the PI3K/Akt/mTOR pathway.
    Gong T; Cui L; Wang H; Wang H; Han N
    J Transl Med; 2018 Jun; 16(1):164. PubMed ID: 29898734
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long noncoding RNA HOTAIR, a hypoxia-inducible factor-1α activated driver of malignancy, enhances hypoxic cancer cell proliferation, migration, and invasion in non-small cell lung cancer.
    Zhou C; Ye L; Jiang C; Bai J; Chi Y; Zhang H
    Tumour Biol; 2015 Dec; 36(12):9179-88. PubMed ID: 26088446
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association of hypoxia inducible factor-1α polymorphisms with susceptibility to non-small-cell lung cancer.
    Kuo WH; Shih CM; Lin CW; Cheng WE; Chen SC; Chen W; Lee YL
    Transl Res; 2012 Jan; 159(1):42-50. PubMed ID: 22153809
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Systematic analysis of IL-6 as a predictive biomarker and desensitizer of immunotherapy responses in patients with non-small cell lung cancer.
    Liu C; Yang L; Xu H; Zheng S; Wang Z; Wang S; Yang Y; Zhang S; Feng X; Sun N; Wang Y; He J
    BMC Med; 2022 May; 20(1):187. PubMed ID: 35550592
    [TBL] [Abstract][Full Text] [Related]  

  • 57. YC-1 potentiates the antitumor activity of gefitinib by inhibiting HIF-1α and promoting the endocytic trafficking and degradation of EGFR in gefitinib-resistant non-small-cell lung cancer cells.
    Hu H; Miao XK; Li JY; Zhang XW; Xu JJ; Zhang JY; Zhou TX; Hu MN; Yang WL; Mou LY
    Eur J Pharmacol; 2020 May; 874():172961. PubMed ID: 32044322
    [TBL] [Abstract][Full Text] [Related]  

  • 58. KLF5 promotes hypoxia-induced survival and inhibits apoptosis in non-small cell lung cancer cells via HIF-1α.
    Li X; Liu X; Xu Y; Liu J; Xie M; Ni W; Chen S
    Int J Oncol; 2014 Oct; 45(4):1507-14. PubMed ID: 25051115
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hypoxia-induced lncRNA-AC020978 promotes proliferation and glycolytic metabolism of non-small cell lung cancer by regulating PKM2/HIF-1α axis.
    Hua Q; Mi B; Xu F; Wen J; Zhao L; Liu J; Huang G
    Theranostics; 2020; 10(11):4762-4778. PubMed ID: 32308748
    [No Abstract]   [Full Text] [Related]  

  • 60. Decursin promotes HIF-1α proteasomal degradation and immune responses in hypoxic tumour microenvironment.
    Ge Y; Yoon SH; Jang H; Jeong JH; Lee YM
    Phytomedicine; 2020 Nov; 78():153318. PubMed ID: 32896707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.